Memorial Sloan Kettering Cancer Center

Event

MSKCC's Molecular Diagnostics in Clinical Practice

presented by Memorial Sloan Kettering Cancer Center

4 others would like to attend.

I need an invite

Notification icon Friday, November 6, 2020 8:30 AM - Saturday, November 7, 2020 5:30 PM America/New_York

Event info


Click HERE to register.

This course will be delivered as a live virtual experience. By registering for the live virtual course, you will be able to view presentations, hear live audio, and interact online.

Overview

Molecular diagnostics is one of the most dynamic and transformative areas in health care. Our ability to properly and successfully utilize this information in routine clinical practice relies on familiarity with the technology, the factors that impact test performance and specific interpretation of results in the context of all available clinicopathologic information. This course will feature a comprehensive overview of the current landscape of molecular diagnostics as it applies to the diagnosis and management of solid tumors and hematologic malignancies. Beginning with a review of key basic and advanced methods of testing, our faculty will illustrate the importance of proper test utilization, specimen handling and outline pre- and post-analytical factors and their impact on test results and patient care. Advantages and disadvantages of different methodologies are also covered. Through a case-based approach, participants will learn about current and evolving clinically relevant biomarkers utilized in clinical practice and clinical trials in the diagnosis, risk assessment, management and monitoring of patients with solid and hematologic neoplasms. 

Objectives

  1. Provide up-to-date information on basic and advance molecular diagnostic methods
  2. Provide up-to-date information on advantages, pitfalls and factors that impact results of molecular testing
  3. Provide up-to-date information on classification and stratification of patients with solid tumors and hematologic malignancies based on current and evolving molecular biomarkers
  4. Provide an overview on how to select a testing method based on the sample and the clinical scenario
  5. Provide a basic review on how to interpret molecular reports and where to obtain additional information 

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Syllabus

Click HERE to view the syllabus

4 others would like to attend.

I need an invite


0 Comments
Login to view comments. Click here to Login